Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01952860 · ClinicalTrials.gov registry record · NA

Hatha Yoga in Lung Cancer Couples

A NA study, sponsored by M.D. Anderson Cancer Center.

Terminated
Registry status
NA
Development phase
30
Enrollment target

NCT01952860: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.

NCT01952860 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01952860, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.

TERMINATED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The goal of this research study is to learn the opinion of patients and their caregiving about a couple-based Hatha Yoga program during treatment for cancer. Researchers also want to learn the effect of this program on lung function, distress, and quality of life.

Primary Outcome

If over 50% of eligible participants participate and at least 80% of the participants are evaluable for follow-up (completing at least one follow-up assessment in the middle of radiotherapy and during the last week of radiotherapy), the study will be deemed feasible.

Interventions

  • BEHAVIORAL Questionnaires
  • OTHER Hatha Yoga

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-09-23
Est. Completion 2019-09-17
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

Why NCT01952860 stopped before completion

NCT01952860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.

NCT01952860 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01952860 about?

NCT01952860 is a clinical study titled "Hatha Yoga in Lung Cancer Couples". The goal of this research study is to learn the opinion of patients and their caregiving about a couple-based Hatha Yoga program during treatment for cancer. Researchers also want to learn the effect of this program on lung function, distress, and quality of life.

What is the current status of trial NCT01952860?

This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2013-09-23. Estimated completion is 2019-09-17.

What interventions are being tested in trial NCT01952860?

The interventions under investigation include: Questionnaires (BEHAVIORAL), Hatha Yoga (OTHER).

Who is sponsoring clinical trial NCT01952860?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01952860's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01952860, the US trial registry maintained by the National Library of Medicine. NCT01952860 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.